Marta C. Guadamillas

Marta C. Guadamillas

Auto-generated profile, based on publicly available information

Marta C. Guadamillas

Integrin Signaling Laboratory, Department of Vascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029 Madrid, Spain

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in Journal of Cell Science
Verified
Journal Article
Closed access
PDF file
MGMarta C. Guadamillas
Marta C. Guadamillas
ACAna Cerezo
Ana Cerezo
MPMiguel A. del Pozo
Miguel A. del Pozo
Anoikis (or cell-detachment-induced apoptosis) is a self-defense strategy that organisms use to eliminate ‘misplaced’ cells, i.e. cells that are in an inappropriate location. Occasionally, detached or misplaced cells can overcome anoikis and survive for a certain period of time in the absence of the correct signals from the extracellular matrix (ECM). If cells are able to adapt to their new environment, then they have probably become anchorage-independent, which is one of the hallmarks of cancer cells. Anoikis resistance and anchorage-independency allow tumor cells to expand and invade adjacent tissues, and to disseminate through the body, giving rise to metastasis. Thus, overcoming anoikis is a crucial step in a series of changes that a tumor cell undergoes during malignant transformation.Tumor cells have developed a variety of strategies to bypass or overcome anoikis. Some strategies consist of adaptive cellular changes that allow the cells to behave as they would in the correct environment, so that induction of anoikis is aborted. Other strategies aim to counteract the negative effects of anoikis induction by hyperactivating survival and proliferative cascades. The recently discovered processes of autophagy and entosis also highlight the contribution of these mechanisms to rendering the cells in a dormant state until they receive a signal initiated at the ECM, thereby circumventing anoikis. In all situations, the final outcome is the ability of the tumor to grow and metastasize. A better understanding of the mechanisms underlying anoikis resistance could help to counteract tumor progression and prevent metastasis formation.

11 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
JTJoseph Jose Thottacherry
Joseph Jose Thottacherry
AKAnita Joanna Kosmalska
Anita Joanna Kosmalska
AKAmit Kumar
Amit Kumar
AVAmit Singh Vishen
Amit Singh Vishen
AEAlberto Elosegui-Artola
Alberto Elosegui-Artola
SMSatyajit Mayor
Satyajit Mayor
Plasma membrane tension regulates many key cellular processes. It is modulated by, and can modulate, membrane trafficking. However, the cellular pathway(s) involved in this interplay is poorly understood. Here we find that, among a number of endocytic processes operating simultaneously at the cell surface, a dynamin independent pathway, the CLIC/GEEC (CG) pathway, is rapidly and specifically upregulated upon a sudden reduction of tension. Moreover, inhibition (activation) of the CG pathway results in lower (higher) membrane tension. However, alteration in membrane tension does not directly modulate CG endocytosis. This requires vinculin, a mechano-transducer recruited to focal adhesion in adherent cells. Vinculin acts by controlling the levels of a key regulator of the CG pathway, GBF1, at the plasma membrane. Thus, the CG pathway directly regulates membrane tension and is in turn controlled via a mechano-chemical feedback inhibition, potentially leading to homeostatic regulation of membrane tension in adherent cells.

1 January 2010 in Developmental Cell
Verified
Journal Article
Closed access
PGPilar Gonzalo
Pilar Gonzalo
MGMarta C. Guadamillas
Marta C. Guadamillas
MHMaría Victoria Hernández-Riquer
María Victoria Hernández-Riquer
ÁPÁngela Pollán
Ángela Pollán
AGAraceli Grande-García
Araceli Grande-García
AAAlicia G. Arroyo
Alicia G. Arroyo

1 February 2015 in Developmental Cell
Verified
Journal Article
Closed access
ILInmaculada Lérida
Inmaculada Lérida
TPTeijo Pellinen
Teijo Pellinen
SSSusana A. Sanchez
Susana A. Sanchez
MGMarta C. Guadamillas
Marta C. Guadamillas
YWYinhai Wang
Yinhai Wang
MPMiguel A. del Pozo
Miguel A. del Pozo

1 September 2009 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
ACAna Cerezo
Ana Cerezo
MGMarta C. Guadamillas
Marta C. Guadamillas
JGJacky G. Goetz
Jacky G. Goetz
SSSara Sánchez-Perales
Sara Sánchez-Perales
EKEric Klein
Eric Klein
MPMiguel A. del Pozo
Miguel A. del Pozo
Anchorage-independent growth (AIG) of cancer cells requires escape from integrin-mediated signals. A protein frequently downregulated in cancer, caveolin-1 (Cav1), mediates integrin control of several growth-regulatory pathways. We report that loss of Cav1 results in faster exit from quiescence and progress through the cell cycle, proliferation without anchorage to substrate, and absence of cyclin D1 downregulation upon serum deprivation or detachment. Surprisingly, this proliferative advantage is independent of Erk-mitogen-activated protein kinase signaling; instead, cyclin expression and cell cycle progression in the absence of Cav1 are driven by increased membrane order and Rac targeting. AIG was induced in Cav1-expressing cells by forced membrane targeting of Rac1 or by inhibiting Cav1-mediated internalization of plasma membrane ordered domains at which Rac1 accumulates. Restoring Rho activity, which is downregulated after loss of Cav1, antagonizes Rac1 and prevents cyclin D1 accumulation after serum starvation or loss of adhesion. Anchorage independence and increased proliferation in Cav1-deficient tumoral and null cells are thus due to an increased fraction of active Rac1 at membrane ordered domains. These results provide insight into the mechanisms regulating growth of cancer cells, which frequently lose Cav1 function.

14 April 2016 in Blood
Verified
Journal Article
Closed access
PDF file
ASAnne Schönle
Anne Schönle
FHFrederike A. Hartl
Frederike A. Hartl
JMJan Mentzel
Jan Mentzel
TNTheresa Nöltner
Theresa Nöltner
KRKatharina S. Rauch
Katharina S. Rauch
RZRobert Zeiser
Robert Zeiser
Caveolin-1 (Cav-1) is a key organizer of membrane specializations and a scaffold protein that regulates signaling in multiple cell types. We found increased Cav-1 expression in human and murine T cells after allogeneic hematopoietic cell transplantation. Indeed, Cav-1−/− donor T cells caused less severe acute graft-versus-host disease (GVHD) and yielded higher numbers of regulatory T cells (Tregs) compared with controls. Depletion of Tregs from the graft abrogated this protective effect. Correspondingly, Treg frequencies increased when Cav-1−/− T cells were exposed to transforming growth factor-β/T-cell receptor (TCR)/CD28 activation or alloantigen stimulation in vitro compared with wild-type T cells. Mechanistically, we found that the phosphorylation of Cav-1 is dispensable for the control of T-cell fate by using a nonphosphorylatable Cav-1 (Y14F/Y14F) point-mutation variant. Moreover, the close proximity of lymphocyte-specific protein tyrosine kinase (Lck) to the TCR induced by TCR-activation was reduced in Cav-1−/− T cells. Therefore, less TCR/Lck clustering results in suboptimal activation of the downstream signaling events, which correlates with the preferential development into a Treg phenotype. Overall, we report a novel role for Cav-1 in TCR/Lck spatial distribution upon TCR triggering, which controls T-cell fate toward a regulatory phenotype. This alteration translated into a significant increase in the frequency of Tregs and reduced GVHD in vivo. Key Points Cav-1–deficient T cells preferentially differentiate into Tregs, which translates into lower GVHD severity in mice. Reduced TCR:Lck clustering in Cav-1–deficient T cells is responsible for reduced TCR downstream signaling events promoting Treg differentiation.